S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?

Sosei Group (SOLTF) Stock Forecast & Price Target

$8.72
0.00 (0.00%)
(As of 02/26/2024 ET)

Sosei Group Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Strong Sell
Based on 2 Analyst Ratings

Analysts' Consensus Price Target

N/A

TypeCurrent Forecast
2/27/23 to 2/27/24
1 Month Ago
1/28/23 to 1/28/24
3 Months Ago
11/29/22 to 11/29/23
1 Year Ago
2/27/22 to 2/27/23
Consensus Rating
Strong Sell
Strong Sell
Strong Sell
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
N/A
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
N/A
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
N/A
Consensus Price TargetN/AN/AN/AN/A
Predicted UpsideN/AN/AN/AN/A
Get Sosei Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SOLTF and its competitors with MarketBeat's FREE daily newsletter.


SOLTF Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SOLTF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sosei Group Stock vs. The Competition

TypeSosei GroupMedical CompaniesS&P 500
Consensus Rating Score
1.00
2.67
2.48
Consensus RatingStrong SellModerate BuyHold
Predicted Upside1,858.63% Upside8.21% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/28/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Sell
6/27/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Underperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:22 AM ET.












SOLTF Price Target - Frequently Asked Questions

What is Sosei Group's consensus rating?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Sosei Group stock is Sell based on the current 2 sell ratings for SOLTFthe . Learn more on SOLTF's analyst rating history.

Do Wall Street analysts like Sosei Group more than its competitors?

Analysts like Sosei Group less than other Medical companies. The consensus rating for Sosei Group is Strong Sell while the average consensus rating for medical companies is Moderate Buy. Learn more on how SOLTF compares to other companies.


Stock Ratings Reports and Tools

This page (OTCMKTS:SOLTF) was last updated on 2/27/2024 by MarketBeat.com Staff